Skip to ContentSkip to Navigation
How to find us dr. A. Veringa, MSc


Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients

Clinical pharmacology and therapeutic drug monitoring of voriconazole

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations

Posaconazole trough concentrations are not influenced by inflammation: A prospective study

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

Bioavailability of voriconazole in hospitalised patients

Low Caspofungin Exposure in Patients in Intensive Care Units

Pharmacokinetic properties of micafungin in critically ill patients diagnosed with invasive candidiasis

The effect of inflammation on voriconazole trough concentrations in children

Voriconazole metabolism is influenced by severe inflammation: a prospective study

Read more